1. Home
  2. RNXT vs NTWK Comparison

RNXT vs NTWK Comparison

Compare RNXT & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • NTWK
  • Stock Information
  • Founded
  • RNXT 2012
  • NTWK 1997
  • Country
  • RNXT United States
  • NTWK United States
  • Employees
  • RNXT N/A
  • NTWK N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • RNXT Health Care
  • NTWK Technology
  • Exchange
  • RNXT Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • RNXT 31.6M
  • NTWK 31.1M
  • IPO Year
  • RNXT 2021
  • NTWK 1998
  • Fundamental
  • Price
  • RNXT $1.16
  • NTWK $2.69
  • Analyst Decision
  • RNXT Strong Buy
  • NTWK
  • Analyst Count
  • RNXT 1
  • NTWK 0
  • Target Price
  • RNXT $9.00
  • NTWK N/A
  • AVG Volume (30 Days)
  • RNXT 203.6K
  • NTWK 16.8K
  • Earning Date
  • RNXT 03-31-2025
  • NTWK 02-13-2025
  • Dividend Yield
  • RNXT N/A
  • NTWK N/A
  • EPS Growth
  • RNXT N/A
  • NTWK N/A
  • EPS
  • RNXT N/A
  • NTWK 0.06
  • Revenue
  • RNXT N/A
  • NTWK $61,749,408.00
  • Revenue This Year
  • RNXT N/A
  • NTWK N/A
  • Revenue Next Year
  • RNXT N/A
  • NTWK N/A
  • P/E Ratio
  • RNXT N/A
  • NTWK $42.95
  • Revenue Growth
  • RNXT N/A
  • NTWK 14.50
  • 52 Week Low
  • RNXT $0.77
  • NTWK $2.28
  • 52 Week High
  • RNXT $1.86
  • NTWK $3.34
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 38.10
  • NTWK 52.26
  • Support Level
  • RNXT $1.32
  • NTWK $2.60
  • Resistance Level
  • RNXT $1.40
  • NTWK $2.78
  • Average True Range (ATR)
  • RNXT 0.09
  • NTWK 0.13
  • MACD
  • RNXT -0.03
  • NTWK 0.01
  • Stochastic Oscillator
  • RNXT 17.07
  • NTWK 65.38

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

Share on Social Networks: